PRA Health Sciences (PRAH) Tops Q2 EPS by 4c, Revenues Beat Offers FY18 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to PRA Health Sciences (PRAH) Tops Q2 EPS by 4c, Revenues Beat Offers FY18 Outlook

PRA Health Sciences, Inc. Reports Second Quarter 2018 Results and Updates Full Year 2018 Guidance

August 1, 2018 4:00 PM EDT

Net new business of $670.0 million; Net book-to-bill of 1.30$722.8 million of revenue; 35.4% growth at actual foreign exchange rates and 34.2% growth on a constant currency basis$575.0 million of revenue excluding the impact of ASC 606; 25.6% actual growth and 12.9% organic growth at actual foreign exchange rates; 24.4% growth and 11.7% organic growth on a constant currency basisGAAP net income per diluted share of $0.64 and GAAP net income of $42.0 millionAdjusted net income per diluted share was $1.00 and adjusted net income was $66.1 millionUpdating full year 2018 revenue guidance between $2.87 billion... More